CClinicalTrials.gg
CompletedNCT01373424DCPUpdated Oct 26, 2020

The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias

An observational study in Dystonia, sponsored by Emory University. Completed at 42 sites in 7 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-10-26.

Sponsored by Emory University · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
3,265
Ages
18 Years and older
Sex
All
01

Study summary

Dystonia is a disorder characterized by excessive involuntary contraction of muscles with repetitive and patterned movements. The isolated dystonias are the most common type of dystonia and include Limb dystonias (like writer's cramp), Cervical dystonia (spasmodic torticollis), Laryngeal dystonias (like spasmodic dysphonia), and Craniofacial dystonias (like blepharospasm). The purpose of this study is to create resources to help learn more about the isolated dystonias, myoclonus dystonia, and dopa-responsive dystonia and to develop and validate various dystonia rating scales.

Read the detailed description

This collaborative, international effort has one primary goal. This is to create a biospecimen repository and associated clinical database to be used as a resource for dystonia and related disease research. Across sites, the investigators hope to enroll at least 5,000 adult patients.

Subjects of this study will be asked to complete a neurological exam which will be video recorded, complete some questionnaires, and donate a blood sample. A study visit will take between 45 minutes and 1 hour. All subjects will be asked to return every 1, 2, 3, or 4 years for a one hour follow-up visit. People may participate in this study without agreeing to participate in the follow-up visits.

02

Conditions studied

  • Dystonia

Keywords

  • Observational study
  • Cross-sectional and Prospective study
  • Cohort and case-control study
03

In context

Dystonia

319 studies on the registry are indexed under Dystonia; 56 are open to participants now.

This study's enrollment of 3,265 is above the median of 60 across 126 observational studies indexed under Dystonia.

Browse Dystonia studies →

Lead sponsor

Emory University is the lead sponsor of 1,386 studies on the registry; 236 are open to participants now.

Of its 229 completed or terminated interventional studies of FDA-regulated products, 174 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

People with dystonia are eligible to participate as long as they are above age 18 and fit the eligibility criteria. The coordinator at the site you contact can tell you more about this.

Inclusion criteria

  • Diagnosed with isolated dystonia or myoclonus dystonia or dopa-responsive dystonia
  • To be included in laryngeal dystonia group, nasolaryngoscopy (voice box exam) must have been completed to confirm diagnosis (this voice box exam is not part of the study)

Exclusion criteria

Exclusion Criteria:

  • Any evidence of a secondary cause for dystonia (other than myoclonus dystonia or dopa-responsive dystonia)
  • Less than 2 months since last botulinum toxin injection
  • Inability to provide informed consent
  • Significant medical or neurological conditions that preclude completing the neurological exam
  • Significant physical or other condition that would confound diagnosis or evaluation, other than dystonia or tremor
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
3,265 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Cervical dystonia

    People diagnosed with cervical dystonia

  • Laryngeal dystonia

    People diagnosed with laryngeal dystonia

  • Other voice disorders

    People diagnosed with a voice disorder other than laryngeal dystonia - enrollment for this group is complete

  • Craniofacial dystonia

    People diagnosed with craniofacial dystonia (including blepharospasm, meige syndrome, and oromandibular dystonia)

  • Limb dystonia

    People diagnosed with limb dystonia

  • All other isolated dystonias

    People diagnosed with any isolated dystonia not listed in descriptions of other cohorts

  • Myoclonus dystonia

    People diagnosed with myoclonus dystonia

  • Dopa-responsive dystonia

    People diagnosed with dopa-responsive dystonia

06

What researchers measure

Primary outcomes

  1. Observational

    There is no primary outcome measure as this is an observational study.

    Time frame: 7 years

07

Study locations

42 sites
  • University of Alabama, Birmingham
    Birmingham, Alabama 35233, United States
  • Mayo Clinic, Arizona
    Scottsdale, Arizona 85259, United States
  • Parkinson's and Movement Disorders Institute
    Fountain Valley, California 72708, United States
  • University of California, San Diego
    La Jolla, California 92037, United States
  • University of Colorado, Denver
    Denver, Colorado 80045, United States
  • University of Florida, Gainesville
    Gainesville, Florida 32611, United States
  • Emory University
    Atlanta, Georgia 30322, United States
  • Rush University
    Chicago, Illinois 60612, United States
  • University of Chicago
    Chicago, Illinois 60637, United States
  • University of Iowa
    Iowa City, Iowa 52242, United States
  • University of Maryland
    Baltimore, Maryland 21201, United States
  • Johns Hopkins University
    Baltimore, Maryland 21287, United States
  • National Institutes of Health
    Bethesda, Maryland 20892, United States
  • Parkinson's and Movement Disorders Center of Maryland
    Elkridge, Maryland 21075, United States
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215, United States
  • Lahey Hospital and Medical Center
    Burlington, Massachusetts 01805, United States
  • Washington University in St. Louis
    Saint Louis, Missouri 63110, United States
  • University of New Mexico
    Albuquerque, New Mexico 87113, United States
  • Mount Sinai Beth Israel
    New York, New York 10003, United States
  • Mount Sinai Medical Center
    New York, New York 10029, United States
  • University of Rochester
    Rochester, New York 14618, United States
  • Wake Forest
    Winston-Salem, North Carolina 27157, United States
  • Sanford Health - Fargo
    Fargo, North Dakota 58103, United States
  • University of Cincinnati
    Cincinnati, Ohio 45219, United States
  • University of Pennsylvania, Parkinson's Disease and Movement Disorders Center
    Philadelphia, Pennsylvania 19107, United States
  • University of Tennessee
    Memphis, Tennessee 38163, United States
  • University of Texas, Southwestern
    Dallas, Texas 75390, United States
  • Baylor College of Medicine
    Houston, Texas 77030, United States
  • Houston Methodist Neurological Institute
    Houston, Texas 77030, United States
  • University of Texas
    Houston, Texas 77030, United States
  • James Madison University
    Harrisonburg, Virginia 22807, United States
  • Virginia Commonwealth University
    Richmond, Virginia 23298, United States
  • Booth Gardner Parkinson's Care Center
    Kirkland, Washington 98034, United States
  • Medical College of Wisconsin
    Milwaukee, Wisconsin 53226, United States
  • Westmead Hospital
    Westmead, Australia
  • University of Alberta
    Edmonton, Alberta T6G 2B7, Canada
  • Toronto Western Hospital
    Toronto, Ontario MST 258, Canada
  • Centre Hospitalier de l'Universite de Montreal
    Montreal, Quebec H2C 4M1, Canada
  • Hopital de la Salpetriere
    Paris, France
  • University Hospital of Schleswig-Holstein
    Luebeck, 23562, Germany
  • University of Rome
    Rome, Italy
  • University College London Institute of Neurology
    London, WC1N 3BG, United Kingdom
08

References and documents

Publications

  • Patel N, Hanfelt J, Marsh L, Jankovic J; members of the Dystonia Coalition. Alleviating manoeuvres (sensory tricks) in cervical dystonia. J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):882-4. doi: 10.1136/jnnp-2013-307316. Epub 2014 May 14. PubMed 24828895 ↗

Study documents

  • Informed consent form · Aug 3, 2016

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Data is available to researchers with appropriate ethics board approvals. Researchers may contact the Dystonia Coalition PI or coordinator at Emory University or the RDCRN Data Management and Coordination Center for more information.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 26, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01373424
Lead sponsor
Emory University
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS), Office of Rare Diseases (ORD), Allergan, Dystonia Study Group
Responsible party
Hyder A. Jinnah, MD, PhD (Principal Investigator, Emory University) — Principal investigator
First posted
Jun 15, 2011
Start date
Jan 2011
Primary completion
Sep 30, 2020
Completion
Sep 30, 2020
Last update
Oct 26, 2020

Study contacts

H. A. Jinnah, MD, PhD
principal investigator · Emory University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion